HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,917,154 | +3.5% | 77,078 | -8.0% | 0.05% | +6.1% |
| Q2 2023 | $8,617,287 | +27.6% | 83,785 | +35.4% | 0.05% | +6.5% |
| Q1 2023 | $6,752,055 | -28.4% | 61,866 | -25.4% | 0.05% | -41.8% |
| Q4 2022 | $9,432,313 | +45.3% | 82,885 | -21.0% | 0.08% | +14.5% |
| Q3 2022 | $6,491,000 | +81.9% | 104,885 | +134.5% | 0.07% | +109.1% |
| Q2 2022 | $3,568,000 | -36.1% | 44,731 | -15.7% | 0.03% | 0.0% |
| Q1 2022 | $5,583,000 | -1.2% | 53,064 | +1.2% | 0.03% | +10.0% |
| Q4 2021 | $5,648,000 | +78.3% | 52,414 | +81.3% | 0.03% | +36.4% |
| Q3 2021 | $3,168,000 | +21.0% | 28,918 | +3.4% | 0.02% | +37.5% |
| Q2 2021 | $2,618,000 | +581.8% | 27,962 | +570.9% | 0.02% | +433.3% |
| Q1 2021 | $384,000 | -17.9% | 4,168 | -34.9% | 0.00% | -40.0% |
| Q4 2020 | $468,000 | +12.2% | 6,399 | +19.2% | 0.01% | 0.0% |
| Q3 2020 | $417,000 | +15.5% | 5,370 | -17.2% | 0.01% | 0.0% |
| Q2 2020 | $361,000 | -17.6% | 6,487 | -46.4% | 0.01% | -28.6% |
| Q4 2019 | $438,000 | -16.1% | 12,104 | -36.9% | 0.01% | -12.5% |
| Q3 2019 | $522,000 | +101.5% | 19,176 | +77.8% | 0.01% | +60.0% |
| Q2 2019 | $259,000 | – | 10,783 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |